Literature DB >> 25346645

A Kappa Opioid Model of Atypical Altered Consciousness and Psychosis: U50488, DOI, AC90179 Effects on Prepulse Inhibition and Locomotion in Mice.

Michael A Ruderman1, Susan B Powell1, Mark A Geyer1.   

Abstract

Sensorimortor gating and locomotion are behaviors that reflect pre-attentive sensory filtering and higher order, top-down, sensory processing, respectively. These processes are thought to affect either the perception of novelty in an environment (filtering) or cognition (higher order processing), salient features of models of altered states of consciousness (ASC). Drugs with highly selective receptor affinities that produce ASC can help to establish neural correlates, pathways, and mechanisms underlying ASC. Furthermore, screening for substances that selectively reverse drug-induced sensory processing departures is valuable for development of experimental antipsychotics. This study investigated the anomalous opioid sub-type, the kappa opioid (KA) system, within the two ASC models. Significant interaction and reversal effects between KA and the serotonin/2A (5-HT2A) system - the serotonin sub-type associated with classical psychedelics - were observed in three BPM measures. These measures showed that KA activation-induced effects could be reversed by 5-HT2A deactivation. These results suggest that KA could function as an atypical antipsychotic medications and/or as a screening tool for new antipsychotic medicines. The experimental work for this study comprised dose-response and reversal experiments with drugs that activate and deactivate kappa opioid and serotonin systems in the two behavioral models for the first time in mice.

Entities:  

Year:  2009        PMID: 25346645      PMCID: PMC4208663     

Source DB:  PubMed          Journal:  J Young Investig        ISSN: 1539-4026


  23 in total

1.  Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.

Authors:  Javier González-Maeso; Noelia V Weisstaub; Mingming Zhou; Pokman Chan; Lidija Ivic; Rosalind Ang; Alena Lira; Maria Bradley-Moore; Yongchao Ge; Qiang Zhou; Stuart C Sealfon; Jay A Gingrich
Journal:  Neuron       Date:  2007-02-01       Impact factor: 17.173

2.  Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats.

Authors:  Marco Bortolato; Gian Nicola Aru; Roberto Frau; Marco Orrù; Mauro Fà; Mario Manunta; Mara Puddu; Giampaolo Mereu; Gian Luigi Gessa
Journal:  Biol Psychiatry       Date:  2005-06-15       Impact factor: 13.382

3.  Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans.

Authors:  S L Walsh; E C Strain; M E Abreu; G E Bigelow
Journal:  Psychopharmacology (Berl)       Date:  2001-09       Impact factor: 4.530

4.  Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans.

Authors:  F X Vollenweider; S Remensberger; D Hell; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1999-04       Impact factor: 4.530

5.  The therapeutic role of naltrexone in negative symptom schizophrenia.

Authors:  G F Marchesi; G Santone; P Cotani; A Giordano; F Chelli
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1995-12       Impact factor: 5.067

6.  A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.

Authors:  R Y Peng; R S Mansbach; D L Braff; M A Geyer
Journal:  Neuropsychopharmacology       Date:  1990-06       Impact factor: 7.853

7.  [The role of serotonin in the behavioral changes induced in the rat by cyclazocine].

Authors:  M R Gavend; F Serre-Debeauvais; M Gavend
Journal:  J Pharmacol       Date:  1986 Oct-Dec

8.  5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex.

Authors:  G C Rigdon; J K Weatherspoon
Journal:  J Pharmacol Exp Ther       Date:  1992-11       Impact factor: 4.030

9.  Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys.

Authors:  A H Tang; R J Collins
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

Authors:  R S Mansbach; M A Geyer
Journal:  Neuropsychopharmacology       Date:  1989-12       Impact factor: 7.853

View more
  1 in total

Review 1.  A New Perspective on Delusional States - Evidence for Claustrum Involvement.

Authors:  Maria Cristina Patru; David H Reser
Journal:  Front Psychiatry       Date:  2015-11-09       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.